BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schmidt AM, Escher U, Mousavi S, Boehm M, Backert S, Bereswill S, Heimesaat MM. Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice. Front Cell Infect Microbiol 2019;9:79. [PMID: 30984628 DOI: 10.3389/fcimb.2019.00079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sharafutdinov I, Tegtmeyer N, Müsken M, Backert S. Campylobacter jejuni Serine Protease HtrA Induces Paracellular Transmigration of Microbiota across Polarized Intestinal Epithelial Cells. Biomolecules 2022;12:521. [DOI: 10.3390/biom12040521] [Reference Citation Analysis]
2 Zarzecka U, Grinzato A, Kandiah E, Cysewski D, Berto P, Skorko-Glonek J, Zanotti G, Backert S. Functional analysis and cryo-electron microscopy of Campylobacter jejuni serine protease HtrA. Gut Microbes 2020;12:1-16. [PMID: 32960677 DOI: 10.1080/19490976.2020.1810532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
3 Callahan SM, Dolislager CG, Johnson JG. The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease. Infect Immun 2021;89:e0011621. [PMID: 34031129 DOI: 10.1128/IAI.00116-21] [Reference Citation Analysis]
4 Xi, Hofmann L, Alter T, Einspanier R, Bereswill S, Heimesaat MM, Gölz G, Sharbati S. The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice. Gut Pathog 2021;13:42. [PMID: 34183045 DOI: 10.1186/s13099-021-00437-1] [Reference Citation Analysis]
5 Xue R, Liu C, Xiao Q, Sun S, Zou Q, Li H. HtrA family proteases of bacterial pathogens: pros and cons for their therapeutic use. Clinical Microbiology and Infection 2021;27:559-64. [DOI: 10.1016/j.cmi.2020.12.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Heimesaat MM, Mousavi S, Weschka D, Bereswill S. Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis. Microorganisms 2021;9:169. [PMID: 33466708 DOI: 10.3390/microorganisms9010169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Mousavi S, Weschka D, Bereswill S, Heimesaat MM. Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10-/- Mice. Pathogens 2020;10:7. [PMID: 33374868 DOI: 10.3390/pathogens10010007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
8 Kløve S, Genger C, Weschka D, Mousavi S, Bereswill S, Heimesaat MM. Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10-/- Mice. Microorganisms 2020;8:E1882. [PMID: 33261211 DOI: 10.3390/microorganisms8121882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Heimesaat MM, Schmidt AM, Mousavi S, Escher U, Tegtmeyer N, Wessler S, Gadermaier G, Briza P, Hofreuter D, Bereswill S, Backert S. Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis. Gut Microbes 2020;12:1770017. [PMID: 32584649 DOI: 10.1080/19490976.2020.1770017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Genger C, Kløve S, Mousavi S, Bereswill S, Heimesaat MM. The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection. Eur J Microbiol Immunol (Bp) 2020. [PMID: 32590346 DOI: 10.1556/1886.2020.00004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mousavi S, Bereswill S, Heimesaat MM. Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis. Microorganisms 2020;8:E482. [PMID: 32231139 DOI: 10.3390/microorganisms8040482] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
12 Butkevych E, Lobo de Sá FD, Nattramilarasu PK, Bücker R. Contribution of Epithelial Apoptosis and Subepithelial Immune Responses in Campylobacter jejuni-Induced Barrier Disruption. Front Microbiol 2020;11:344. [PMID: 32210941 DOI: 10.3389/fmicb.2020.00344] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
13 Mousavi S, Lobo de Sá FD, Schulzke JD, Bücker R, Bereswill S, Heimesaat MM. Vitamin D in Acute Campylobacteriosis-Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model. Front Immunol 2019;10:2094. [PMID: 31552040 DOI: 10.3389/fimmu.2019.02094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]